Becton, Dickinson and Company
https://www.bd.com/en-us
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Becton, Dickinson and Company
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.
South Korea Sees Pharma Leadership Transition
Leadership succession is proceeding within South Korean pharmaceutical corporations such as Daiichi Sankyo Korea, Astellas Pharma Korea, Kyowa Kirin Korea as well as MSD Korea.
Finance Watch: Ten IPOs So Far In 2024, But Returns To Date Are Subpar
Public Company Edition: This year’s newly public companies are trading an average of 9.7% below their IPO prices, including the two most recent debuts, Boundless Bio and Contineum. Also, Nkarta, Praxis and Nurix grossed $240m, $200m and $175m, respectively, in follow-on offerings.
Coming Of Age: Pharma’s Influencer Marketing Matures
Influencer marketing has emerged as a potent tool for many industries and is a sector set to be worth $22bn in its own right by 2025.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Drug Delivery
-
Medical Devices
- Diagnostic Equipment & Supplies
- Implantable Devices
-
Biotechnology
- Drug Discovery Tools
- Other Names / Subsidiaries
-
- BD
- BD Medical
- Bridger Biomed, Inc.
- Caesarea Medical Electronics
- CareFusion
- Carmel Pharma, Inc.
- Carmel Pharma, AB
- Cellular Research, Inc.
- C.R. Bard, Inc.
- CRISI Medical Systems
- Davol, Inc.
- Embo Medical Limited
- FlowCardia, Inc.
- GenCell Biosystems, Ltd.
- GeneOhm Sciences
- Liberator Medical, Inc.
- Lutonix, Inc.
- Medafor, Inc.
- Medicon, Inc.
- Neomend, Inc.
- Sirigen Group Limited
- TriPath Imaging
- TVA Medical, Inc.
- Rochester Medical, Inc.
- Safety Syringes Inc.
- Vascular Pathways, Inc.
- Venclose, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice